News and Analysis

Tara Biosystems nabs $10m Series A2

New York City-based Tara Biosystems, Inc., a provider of predictive cardiac physiology, has raised $10 million in Series A2 financing.

-

New York City-based Tara Biosystems, Inc., a provider of predictive cardiac physiology, has raised $10 million in Series A2 financing. The investors included OMX Ventures, Merieux Equity Partners, LifeForce Capital, Alexandria Venture Investments, Partnership Fund for New York City, Trancos Ventures, DEFTA Partners, New York Ventures and Tachyon Ventures.

Source: Press Release